首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1533589

神经血管设备市场规模、份额和增长分析：按产品、疾病病理学、工艺、治疗用途和最终用途 - 行业预测，2024-2031 年

Neurovascular Devices Market Size, Share, Growth Analysis, By Product, By Disease Pathology(Aneurysm, Arteriovenous Malformation and Fistulas ), By Process, By Therapeutic Applications, By End-Use - Industry Forecast 2024-2031

出版日期: 2024年08月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经血管器械市场规模将为29亿美元，从2023年的31.5亿美元成长到2031年的60.4亿美元，在预测期内（2024-2031年）预计复合年增长率为8.5%。

由于几个关键因素，神经血管设备市场有望显着成长。神经系统疾病的日益普及、技术的持续进步以及对微创手术的需求不断增加是这种扩张的核心。此外，主要市场中神经系统疾病患者数量的增加导致对神经血管设备的需求增加。市场成长的主要催化剂是急性缺血性脑中风的高盛行率，这凸显了对有效神经血管解决方案的需求。预计市场还将受益于产品核可以及采用先进技术的新产品发布的激增。然而，严格的法律规范，特别是美国FDA 的法规，确保这些设备符合严格的安全性和有效性标准，最终改善患者照护，儘管这会增加开发成本，从而提高品质。神经血管设备的持续技术创新，包括引入新型栓塞设备、血栓清除系统和先进的微导管，进一步推动了市场成长。美敦力 (Medtronic)、史赛克 (Stryker) 和 Penumbra 等领先公司正在透过尖端产品和技术进步推动市场发展。

市场概况
脑动脉瘤
- 栓塞弹簧圈
可拆裸线圈
涂层可拆线圈
- 流量转换装置
- 颅内支架
- 微导管
- 导管导引线
缺血性中风
- 血栓清除装置
- 吸风/吸风装置
- 血管勒除器
- 微导管
- 微导管导引线
- 球囊导管
颈动脉狭窄
- 颈动脉支架
- 栓塞防护装置
- 球囊导管
动静脉畸形和瘻管
- 液态栓塞剂
- 闭塞球囊导管
- 微导管
其他疾病

神经血管设备市场：依最终用户分类

市场概况
医院/手术中心
门诊治疗中心
实验室/学术机构

按地区分類的神经血管设备市场规模

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Acandis GmbH（Germany）
Asahi Intecc Co. Ltd.（Japan）
Imperative Care Inc.（United States）
Integer Holdings Corporation（United States）
Johnson & Johnson（United States）
Medtronic plc（Ireland）
MicroPort Scientific Corporation（China）
Penumbra Inc.（United States）
Perflow Medical Ltd.（Israel）
Rapid Medical（Canada）
Stryker Corporation（United States）
Terumo Corporation（Japan）
WL Gore & Associates（United States）
Penumbra, Inc.（United States）（duplicate）
Silk Road Medical（United States）
Siemens Healthineers AG（Germany）
Le Maire Vascular（France）
Boston Scientific Corporation（United States）
Balt（Switzerland）
InspireMD, Inc.（Israel）

简介目录

Product Code: SQMIG35A2777

Global Neurovascular Devices Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.15 Billion in 2023 to USD 6.04 Billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The neurovascular devices market is set for significant growth, driven by several key factors. The rising incidence of neurological disorders, ongoing technological advancements, and the growing demand for minimally invasive procedures are central to this expansion. Additionally, the increasing number of patients suffering from neurological conditions in major markets has led to a heightened demand for neurovascular devices. A key catalyst for market growth is the high prevalence of acute ischemic stroke, which underscores the need for effective neurovascular solutions. The market is also expected to benefit from the surge in new product launches featuring advanced technologies, alongside rapid product approvals. However, the stringent regulatory frameworks, particularly the FDA regulations in the United States, ensure that these devices meet rigorous safety and efficacy standards, which can elevate development costs but ultimately enhance patient care quality. Continuous innovation in neurovascular devices, including the introduction of new embolization devices, thrombectomy systems, and advanced microcatheters, is further fueling market growth. Leading companies like Medtronic, Stryker, and Penumbra are at the forefront, driving the market with their cutting-edge products and technological advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurovascular Devices Market Segmental Analysis

The Neurovascular Devices Market is segmented into Disease Pathology, End-User and Region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysm (Embolic Coils [Bare Detachable Coils, Coated Detachable Coils], Flow Diversion Devices, Intracranial Stents, Microcatheters, Guidewires), Arteriovenous Malformation And Fistulas (Liquid Embolic Agents, Occlusion Balloon Catheters, Microcatheters), Ischemic Stroke (Clot Retriever Devices, Suction & Aspiration Devices, Vascular Snares, Microcatheters, Micro Guidewires, Balloon Catheters), Carotid Artery Stenosis (Carotid Artery Stents, Embolic Protection Devices, Balloon Catheters), and Others. Based on End-User, the market is trifurcated into, Hospitals and Surgical Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, LAMEA, and the Middle East and Africa.

Drivers of the Global Neurovascular Devices Market

The growing preference for minimally invasive surgeries is largely due to their significant benefits, such as lower risks and reduced trauma compared to traditional procedures. These surgeries involve smaller incisions, which lead to less postoperative pain and quicker recovery times. This has significantly driven the adoption of minimally invasive techniques and spurred extensive research and development efforts in the field. Leading industry players are investing heavily in developing innovative surgical instruments to advance minimally invasive procedures.

Restraints in the Global Neurovascular Devices Market

Integrating new neurovascular devices into existing medical infrastructure can be challenging and time-consuming. Often, these devices are not fully compatible with current equipment and electronic health record (EHR) systems used in many hospitals. This integration challenge requires substantial time and resources, potentially delaying the deployment of new technologies and increasing costs.

Market Trends of the Global Neurovascular Devices Market

Globally, the rise in minimally invasive surgeries is driven by their aesthetic benefits, such as shorter recovery times, which is expected to further boost the neurovascular devices market. This growth is largely attributed to advancements in innovation and ongoing improvements within surgical techniques, aimed at enhancing patient safety. Developments in laparoscopic and endoscopic procedures, as well as the introduction of robotic surgeries, signify a shift towards more sophisticated techniques. This trend creates a favorable market environment conducive to the continued progress of the neurovascular devices industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Case Study Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Ecosystem of the Market
Start-up Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Global Neurovascular Devices Market by Disease Pathology

Market Overview
Cerebral aneurysms
- Embolic coils
Bare detachable coils
Coated detachable coils
- Flow diversion devices
- Intracranial stents
- Microcatheters
- Guidewires
Ischemic strokes
- Clot retriever devices
- Suction & aspiration devices
- Vascular snares
- Microcatheters
- Micro guidewires
- Balloon catheters
Carotid artery stenosis
- Carotid artery stents
- Embolic protection devices
- Balloon catheters
Arteriovenous malformation & fistulas
- Liquid embolic agents
- Occlusion balloon catheters
- Microcatheters
Other disease pathologies

Global Neurovascular Devices Market by End-user

Market Overview
Hospitals and surgical centres
Ambulatory care centres
Research laboratories and academic institutes

Global Neurovascular Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imperative Care Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perflow Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WL Gore & Associates (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States) (duplicate)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Silk Road Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Le Maire Vascular (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments